Sequence Similarity Clusters for the Entities in PDB 2B2X

Entity #1 | Chains: A,B
Integrin alpha-1 protein, length: 223 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 45453
95 % 1 1 34667 Flexibility: No
Max RMSD: 0.4, Avg RMSD: 0.4
PDBFlex
90 % 8 10 4865
70 % 8 10 4806
50 % 12 26 682
40 % 12 26 709
30 % 12 26 749
Entity #2 | Chains: H,I
Antibody AQC2 Fab protein, length: 226 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 39317
95 % 2 2 26950 Flexibility: Low
Max RMSD: 2.3, Avg RMSD: 1.6
PDBFlex
90 % 3 3 16209
70 % 1292 2903 1
50 % 1365 3048 1
40 % 1365 3048 1
30 % 2708 6095 1
Entity #3 | Chains: L,M
Antibody AQC2 Fab protein, length: 213 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 39314
95 % 2 2 26949 Flexibility: Medium
Max RMSD: 5.7, Avg RMSD: 3.9
PDBFlex
90 % 2 2 26039
70 % 1053 2368 2
50 % 1328 3003 2
40 % 1328 3003 2
30 % 2709 6095 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 4P48 1 A Antibody scFv 180 9031
21 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
22 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
23 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
24 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
25 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
26 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
27 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
28 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
29 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
30 6MEE 2 B, D antibody HEPC74 Light Chain 9606
31 6BJZ 1 H 5c8 Fab Heavy chain 9606
32 6BJZ 2 L 5c8 Fab Light chain 9606
33 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
34 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
35 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
36 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
37 4XCF 1 L 4E10 Fab light chain 9606
38 4XCF 2 H 4E10 Fab heavy chain 9606
39 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
40 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
41 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
42 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
43 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
44 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
45 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
46 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
47 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
48 5X08 1 H Fab 4E10 Heavy chain 9606
49 5X08 2 L Fab 4E10 Light chain 9606
50 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
51 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
52 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
53 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
54 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
55 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
56 6MEG 1 H antibody HEPC46 Heavy Chain 9606
57 6MEG 2 L antibody HEPC46 Light Chain 9606
58 4XAW 1 L 4E10 Fab light chain 9606
59 4XAW 2 H 4E10 Fab heavy chain 9606
60 4P49 1 A Antibody scFv B8 9031
61 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
62 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
63 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
64 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
65 5UCB 1 H Fab Heavy Chain 9606
66 5UCB 2 L Fab Light Chain 9606
67 2VXV 1 H HUMAN IGG ABT-325 9606
68 2VXV 2 L HUMAN IGG ABT-325 9606
69 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
70 4GXV 1 H, I Antibody 1F1, heavy chain 9606
71 4GXV 2 L, M Antibody 1F1, light chain 9606
72 2VXT 1 H MURINE IGG 125-2H 10090
73 2VXT 3 L MURINE IGG 125-2H 10090
74 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
75 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
76 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
77 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
78 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
79 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
80 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
81 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
82 5W24 1 L 5C4 Fab Light Chain 10090
83 5W24 2 H 5C4 Fab Heavy Chain 10090
84 4HPY 1 H CH59 Fab heavy chain 9606
85 4HPY 2 L CH59 Fab light chain 9606
86 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
87 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
88 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
89 4JG1 1 L Fab light chain 9606
90 4JG1 2 H Fab heavy chain 9606
91 6E65 1 L TB31F Fab light chain 9606
92 6E65 2 H TB31F Fab heavy chain 9606
93 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
94 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
95 5VF2 1 A scFv 2D10 10090
96 5I8C 1 A VRC34.01 Fab heavy chain 9606
97 5I8C 2 B VRC34.01 Fab light chain 9606
98 4O5L 1 L Fab F045-092 light chain 9606
99 4O5L 2 H Fab F045-092 heavy chain 9606
100 5MYX 1 A, C Fab c#24 light chain 10090
101 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
102 3IFL 1 L 12A11 FAB antibody light chain 10090
103 3IFL 2 H 12A11 FAB antibody heavy chain 10090
104 5WK2 1 L M116 LIGHT CHAIN 9606
105 5WK2 2 H M116 HEAVY CHAIN FD 9606
106 3PP4 1 H GA101 Fab heavy chain 10090
107 3PP4 2 L GA101 Fab light chain 10090
108 3KDM 1 A, L Immunoglobulin light chain 9606
109 3KDM 2 B, H Immunoglobulin heavy chain 9606
110 5NIV 1 A Light chain of 5D3 Fab 10090
111 5NIV 2 B Heavy chain of 5D3 Fab 10090
112 5N4J 1 L LIGHT CHAIN 9606
113 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
114 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
115 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
116 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
117 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
118 5X4G 1 A 6H8 Fab heavy chain 10090
119 5X4G 2 B 6H8 Fab light chain 10090
120 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
121 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
122 4PTU 1 A Antibody pn132p2C05, light chain 9606
123 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
124 4TPR 1 L If kappa light chain 10090
125 4TPR 2 H Fab heavy chain 10090
126 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
127 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
128 3IFN 1 H 12A11 FAB antibody heavy chain 10090
129 3IFN 2 L 12A11 FAB antibody light chain 10090
130 5U3P 1 H DH511.4 Fab Heavy Chain 9606
131 5U3P 2 L DH511.4 Fab Light Chain 9606
132 6BLA 1 H AMM01 Fab Heavy chain 9606
133 6BLA 2 L AMM01 Fab Light chain 9606
134 4TOY 1 H 35O22 Fab Heavy chain 9606
135 4TOY 2 L 35O22 Fab Light chain 9606
136 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
137 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
138 3NPS 2 B S4 FAB HEAVY CHAIN 9606
139 3NPS 3 C S4 FAB LIGHT CHAIN 9606
140 5I4F 1 A scFv 2D10 10090
141 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
142 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
143 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
144 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
145 5WN9 1 H scFv 2D10 9606
146 4XC3 1 L 4E10 Fab light chain 9606
147 4XC3 2 H 4E10 Fab heavy chain 9606
148 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
149 4M5Y 1 H, I Fab 5J8 heavy chain 9606
150 4M5Y 2 L, M Fab 5J8 light chain 9606
151 4TQE 1 L If kappa light chain 10090
152 4TQE 2 H Fab heavy chain 10090
153 5YY4 1 A scFv 4B08 10090
154 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
155 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
156 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
157 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
158 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
159 5VSI 2 L CH1/Ckappa Fab light chain 9606
160 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
161 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
162 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
163 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
164 5JXA 1 H VRC03 Heavy chain 9606
165 5JXA 2 L VRC03 Light chain 9606
166 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
167 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
168 6QCU 1 L Light chain 9606
169 6QCU 2 H Heavy chain 9606
170 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
171 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
172 3NTC 1 L Fab light chain 10090
173 3NTC 2 H Fab heavy chain 10090
174 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
175 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
176 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
177 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
178 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
179 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
180 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
181 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
182 6BE3 1 H Fab (F598) Heavy Chain 9606
183 6BE3 2 L Fab (F598) Light Chain 9606
184 4NWU 1 H APE1551 Ab Fab heavy chain 9606
185 4NWU 2 L APE1551 Ab Fab light chain 9606
186 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
187 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
188 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
189 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
190 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
191 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
192 5EWI 1 H VRC38.01 Heavy Chain 9606
193 5EWI 2 L VRC38.01 Light Chain 9606
194 5E2W 1 L AT8 LIGHT CHAIN 10090
195 5E2W 2 H AT8 HEAVY CHAIN 10090
196 5MYK 1 A Fab c#17 light chain 10090
197 5MYK 2 B Fab c#17 heavy chain 10090
198 4NZR 1 H PGT135 heavy chain Fab 9606
199 4NZR 2 L PGT135 light chain Fab 9606
200 5MYO 1 A, C Fab c#6 light chain 10090
201 5MYO 2 B, D Fab c#6 heavy chain 10090
202 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
203 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
204 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
205 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
206 5UEL 1 H 354NC102 Fab Heavy Chain 9606
207 5UEL 2 L 354NC102 Fab Light Chain 9606
208 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
209 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
210 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
211 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
212 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
213 5E2V 1 L AT8 LIGHT CHAIN 10090
214 5E2V 2 H AT8 HEAVY CHAIN 10090
215 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
216 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
217 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
218 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
219 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
220 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
221 5JUE 1 L light chain of UIC2 Fab 10090
222 5JUE 2 H heavy chain of UIC2 Fab 10090
223 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
224 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
225 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
226 5JR1 1 H 10E8 heavy chain 9606
227 5JR1 2 L 10E8 mature light chain 9606
228 6CA7 1 L PCT64_13C light chain 9606
229 6CA7 2 H PCT64_13C heavy chain 9606
230 5VF6 1 A single chain variable fragment 9031
231 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
232 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
233 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
234 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
235 6K4Z 1 A, B scFv of C6 The fusion protein of expression tags (residues -2-0), the light chain (residues 1-108), linker GGGGSGGGGSGGGGS (residues 501-515), and the heavy chain (residues 1001-1113) 10090
236 5OB5 2 H fAb Heavy chain 9606
237 5OB5 3 L fAb Light chain 9606
238 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
239 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
240 5I66 1 A 8B6 antibody, heavy chain 10090
241 5I66 2 B 8B6 antibody, light chain 10090
242 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
243 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
244 6BZY 1 H 22D11 Heavy Chain 10090
245 6BZY 2 L 22D11 Light Chain 10090
246 3QQ9 1 C, L 101F LIGHT CHAIN 10090
247 3QQ9 2 D, H 101F HEAVY CHAIN 10090
248 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
249 5TKK 3 L mouse antibody vFP5.01 light chain 10090
250 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
251 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
252 5W6C 1 H UCA Fab heavy chain 9606
253 5W6C 2 L UCA Fab light chain 9606
254 5I1K 1 L FAB LIGHT CHAIN 9606
255 5I1K 2 H FAB HEAVY CHAIN 9606
256 3OZ9 1 L Fab NC-1 kappa light chain 10090
257 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
258 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
259 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
260 5V7U 1 L CBTAU-22.1 Fab light chain 9606
261 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
262 5UEA 1 A, H Fab Heavy Chain 9606
263 5UEA 3 B, L Fab Light Chain 9606
264 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
265 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
266 3G5Y 1 A 175 light chain 10090
267 3G5Y 2 B 175 heavy chain 10090
268 5NMV 1 L Fab light chain 10088
269 5NMV 2 H Fab heavy chain 10088
270 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
271 4N8C 2 L, M Light chain of monoclonal antibody 10090
272 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
273 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
274 4HGW 1 A Antibody Fab fragment, light chain 10090
275 4HGW 2 B Antibody Fab fragment, heavy chain 10090
276 1NLB 1 L antibody 19D9D6 light chain 10090
277 1NLB 2 H antibody 19D9D6 heavy chain 10090
278 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
279 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
280 3VFG 1 L 3F8 Light Chain 10090
281 3VFG 2 H 3F8 Heavy Chain 10090
282 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
283 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
284 3QRG 1 L Fab light chain 9606
285 3QRG 2 H Fab heavy chain Fd fragment 9606
286 5M6A 1 A, B, C, D Bence-Jones light chain 9606
287 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
288 4LLY 2 B, D light chain Clambda 9606
289 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
290 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
291 5EZI 1 H Fab c12 heavy chain 9606
292 5EZI 2 L Fab c12 Light chain 9606
293 4K23 1 H anti-uPAR antibody, heavy chain 10090
294 4K23 2 L anti-uPAR antibody, light chain 10090
295 3NCJ 1 L Fab15 Mut8 light chain 9606
296 3NCJ 2 H Fab15 Mut8 heavy chain 9606
297 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
298 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
299 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
300 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
301 5W05 1 L M59 FAB LIGHT CHAIN 10090
302 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
303 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
304 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
305 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
306 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
307 4M61 1 A, C Fab A52 light chain 10090
308 4M61 2 B, D Fab A52 heavy chain 10090
309 5YE3 1 B 2A7D9 VH CH1 chain 10090
310 5YE3 2 A 2A7D9 L chain 10090
311 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
312 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
313 1UM5 1 L Antibody 21H3 L chain 10090
314 1UM5 2 H Antibody 21H3 H chain 10090
315 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
316 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
317 4NWT 1 L APE1531 Ab Fab light chain 9606
318 4NWT 2 H APE1531 Ab Fab heavy chain 9606
319 3WHX 1 A mAb Fab H fragment 10090
320 3WHX 2 B mAb Fab L fragment 10090
321 3NA9 1 L Fab15 light chain 9606
322 3NA9 2 H Fab15 heavy chain 9606
323 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
324 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
325 6RCO 1 A, C R5.004 heavy chain 9606
326 6RCO 2 B, D R5.004 light chain 9606
327 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
328 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
329 4LRI 1 A, B MSL-109 Light Chain 9606
330 4LRI 2 C, P MSL-109 Heavy Chain 9606
331 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
332 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
333 4JN2 1 A, L anti dabigatran Fab 10090
334 4JN2 2 B, H anti dabigatran Fab 10090
335 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
336 4XBE 2 H 4E10 Fab heavy chain 9606
337 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
338 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
339 6BE2 1 H Fab (F598) Heavy Chain 9606
340 6BE2 2 L Fab (F598) Light Chain 9606
341 4JFZ 1 L Fab light chain 9606
342 4JFZ 2 H Fab heavy chain 9606
343 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
344 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
345 3WIF 1 A mAb Fab H fragment 10090
346 3WIF 2 B mAb Fab L fragment 10090
347 5U6A 1 A Light Chain 9606
348 5U6A 2 B Heavy Chain 9606
349 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
350 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
351 3MBX 1 L X836 LIGHT CHAIN 10090
352 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
353 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
354 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
355 6APC 1 H Epididymis luminal protein 214 9606
356 6APC 2 L IGL@ protein 9606
357 4HHA 1 A Fab KE5 Fab fragment KE5 9606
358 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
359 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
360 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
361 4RGO 2 H 14G8 heavy chain Fab 10090
362 4RGO 3 L 14G8 light chain Fab 10090
363 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
364 5GRY 1 A, G diabody 9606
365 5UEK 2 H Fab 12E Heavy Chain 9606
366 5UEK 3 L Fab 12E Light Chain 9606
367 3NAA 1 L Fab15 Mut5 light chain 9606
368 3NAA 2 H Fab15 Mut5 heavy chain 9606
369 1Q0X 1 L Fab 9B1, light chain 10090
370 1Q0X 2 H Fab 9B1, heavy chain 10090
371 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
372 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
373 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
374 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
375 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
376 5IK3 2 B, D 1E03 Fab fragment light chain 9606
377 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
378 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
379 5XLI 1 a, b FabL 10090
380 5XLI 2 c, d FabH 10090
381 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
382 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
383 6DC4 1 H Fab AM22 Heavy Chain 9606
384 6DC4 2 L Fab AM22 Light Chain 9606
385 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
386 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
387 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
388 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
389 4WUK 1 H CH65 heavy chain 9606
390 4WUK 2 L CH65 light chain 9606
391 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
392 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
393 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
394 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
395 5JOP 1 D, L Fab 14.22 light chain 10090
396 5JOP 2 E, H Fab14.22 heavy chain 10090
397 4HPO 1 H CH58 Fab heavy chain 9606
398 4HPO 2 L CH58 Fab light chain 9606
399 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
400 5UKN 2 L DH522UCA Fab fragment light chain 9544
401 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
402 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
403 5IT2 1 H heavy chain 9606
404 5IT2 2 L light chain 9606
405 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
406 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
407 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
408 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
409 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
410 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
411 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
412 5MO3 3 L Fab of monoclonal antibody, light chain 10090
413 5GZ0 1 A, C FM329 light chain 1383439
414 5GZ0 2 B, D FM329 heavy chain 1383439
415 6DW2 1 A 6078 Fab light chain 9606
416 6DW2 2 B 6078 Fab heavy chain 9606
417 6MG4 1 A, B JTO light chain 9606
418 6BQB 1 L MGG4 Fab light chain 9606
419 6BQB 2 H MGG4 Fab heavy chain 9606
420 4PUB 1 H DX-2930 HEAVY CHAIN 9606
421 4PUB 2 L DX-2930 LIGHT CHAIN 9606
422 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
423 6B14 2 L Light chain of Fab BL3-6S97N 10090
424 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
425 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
426 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
427 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
428 5GS3 1 A, H diabody protein 9606
429 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
430 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
431 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
432 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
433 5VKD 2 H Fab Heavy Chain 9606
434 5VKD 3 L Fab light chain 9606
435 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
436 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
437 5XHG 1 A, C polypeptide(L) 10090
438 5XHG 2 B, D polypeptide(H) 10090
439 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
440 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
441 3UYR 1 H antibody Fab heavy chain 10090
442 3UYR 2 L antibody Fab light chain 10090
443 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
444 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
445 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
446 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
447 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
448 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
449 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
450 3OAZ 2 K, L Fab 2G12, light chain 9606
451 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
452 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
453 1ZAN 1 L Fab AD11 Light Chain 10116
454 1ZAN 2 H Fab AD11 Heavy Chain 10116
455 6CJK 1 A, C Immunoglobulin Fab light chain 9986
456 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
457 4N0Y 1 H IGH526 Heavy Chain 9606
458 4N0Y 2 L IGH526 Light Chain 9606
459 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
460 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
461 6OTC 2 H sFab H3 heavy chain 32630
462 6OTC 3 L sFab H3 light chain 32630
463 5MTH 1 A, H antibody Fab heavy chain 10090
464 5MTH 2 B, L antibody Fab light chain 10090
465 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
466 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
467 1RZF 1 L Fab E51 light chain 9606
468 1RZF 2 H Fab E51 heavy chain 9606
469 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
470 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
471 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
472 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
473 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
474 4KTE 2 L GE148 Light Chain Fab 9544
475 5I8O 1 H HMM5 antibody heavy chain 9606
476 5I8O 2 L HMM5 antibody light chain 9606
477 4OUO 1 A anti Bla g 1 scFv 9031
478 4JG0 1 L Fab light chain 9606
479 4JG0 2 H Fab heavy chain 9606
480 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
481 4YGV 2 B, L aDabi-Fab2a light chain 9606
482 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
483 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
484 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
485 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
486 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
487 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
488 3EO0 1 A, C GC-1008 Fab Light Chain 10090
489 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
490 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
491 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
492 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
493 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
494 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
495 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
496 4FQI 3 H antibody CR9114 heavy chain Fab 9606
497 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
498 6S5A 2 H anti P329G LALA Fab heavy chain 10090
499 6S5A 3 L anti P329G LALA Fab light chain 10090
500 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
501 4JHA 2 L D25 light chain 9606
502 6B9Z 1 A Trastuzumab Fab light chain 10090
503 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
504 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
505 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
506 4PTT 1 A Antibody pn132p2C05, light chain 9606
507 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
508 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
509 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
510 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
511 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
512 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
513 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
514 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
515 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
516 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
517 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
518 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
519 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
520 4DGV 1 H HCV1 Heavy Chain Fab 9606
521 4DGV 2 L HCV1 Light Chain 9606
522 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
523 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
524 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
525 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
526 5TH2 1 A, C cetuximab Fab, light chain 10090
527 5TH2 2 B, D cetuximab Fab, heavy chain 10090
528 5I8K 1 L HHH1 Fab Light chain 9606
529 5I8K 2 H HHH1 Fab Heavy chain 9606
530 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
531 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
532 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
533 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
534 1YNL 1 L Ig gamma light chain 10090
535 1YNL 2 H Ig gamma heavy chain 10090
536 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
537 5EPM 2 B, F Antibody Fab fragment light chain 10090
538 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
539 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
540 3UMT 1 A scFv heavy chain and light chain 10090
541 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
542 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
543 4NUJ 1 A PGT152 light chain 9606
544 4NUJ 2 B PGT152 heavy chain 9606
545 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
546 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
547 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
548 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
549 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
550 3U2S 2 B, L PG9 light chain 9606
551 6PE7 1 H FAB Heavy Chain 9606
552 6PE7 2 L FAB Light chain 9606
553 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
554 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
555 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
556 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
557 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
558 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
559 4NUG 1 L PGT151 light chain 9606
560 4NUG 2 H PGT151 heavy chain 9606
561 3IU4 1 H chP3 Fab heavy chain 10090
562 3IU4 2 L chP3 Fab light chain 10090
563 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
564 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
565 6DC8 1 L IgG light chain 10090
566 6DC8 2 H IgG heavy chain 10090
567 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
568 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
569 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
570 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
571 6IAS 1 H Fab NKp46-1 heavy chain 32630
572 6IAS 2 L Fab NKp46-1 light chain 32630
573 1P7K 1 A, L antibody light chain FAB 10090
574 1P7K 2 B, H antibody heavy chain FAB 10090
575 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
576 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
577 3RVV 2 C 4C1 - light chain 10090
578 3RVV 3 D 4C1 - heavy chain 10090
579 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
580 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
581 3P0Y 2 H Fab DL11 heavy chain 9606
582 3P0Y 3 L Fab DL11 light chain 9606
583 4NPY 1 A, L germline PGT121 light chain Fab 9606
584 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
585 6ANA 2 H LL2 Fab Heavy Chain 10090
586 6ANA 3 L LL2 Fab Light Chain 10090
587 5IBU 1 B, L 6652 Light Chain 9606
588 5IBU 2 G, H 6652 Heavy Chain 9606
589 5VPL 2 C 4C1 - LIGHT CHAIN 10090
590 5VPL 3 D 4C1 - HEAVY CHAIN 10090
591 6AOD 1 A FXIa Antibody FAB Light Chain 9606
592 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
593 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
594 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
595 2YPV 2 H FAB 12C1 10090
596 2YPV 3 L FAB 12C1 10090
597 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
598 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
599 4JY5 1 L PGT122 light chain Fab 9606
600 4JY5 2 H PGT122 heavy chain Fab 9606
601 6ELE 1 A, H fAB heavy chain 9606
602 6ELE 2 B, L fAB light chain 9606
603 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
604 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
605 6B5R 1 H CIS42 Fab Heavy chain 9606
606 6B5R 2 L CIS42 Fab Light chain 9606
607 3NAC 1 L Fab15 Mut7 light chain 9606
608 3NAC 2 H Fab15 Mut7 heavy chain 9606
609 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
610 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
611 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
612 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
613 1Q72 1 L Fab M82G2, Light chain 10090
614 1Q72 2 H Fab M82G2, Heavy chain 10090
615 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
616 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
617 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
618 6MNQ 3 L Ab DH727.2 light chain 9544
619 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
620 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
621 4YHO 1 H aDabi-Fab3 heavy chain 9606
622 4YHO 2 L aDabi-Fab3 light chain 9606
623 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
624 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
625 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
626 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
627 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
628 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
629 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
630 4DGY 1 H HCV1 Heavy Chain Fab 9606
631 4DGY 2 L HCV1 Light Chain 9606
632 5EN2 1 A GD01 heavy chain 10090
633 5EN2 2 B GD01 light chain 10090
634 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
635 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
636 6P4Y 1 H 4A10 Fab heavy chain 10090
637 6P4Y 2 L 4A10 Fab light chain 10090
638 3MXW 2 L 5E1 light chain 9606
639 3MXW 3 H 5E1 heavy chain 9606
640 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
641 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
642 3EO9 1 L Efalizumab Fab fragment, light chain 9606
643 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
644 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
645 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
646 6N35 1 K, L Fab 2G12 light chain 9606
647 6N35 2 H, M Fab 2G12 heavy chain 9606
648 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
649 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
650 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
651 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
652 5WUV 1 L light chain 9606
653 5WUV 2 H heavy chain 9606
654 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
655 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
656 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
657 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
658 4JM4 1 H PGT 135 Heavy Chain Fab 9606
659 4JM4 2 L PGT 135 Light Chain Fab 9606
660 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
661 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
662 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
663 5YE4 2 B, D 1A9D7 L chain 10090
664 6B0G 1 C 1245 Antibody, Light Chain 9606
665 6B0G 2 D 1245 Antibody, Heavy Chain 9606
666 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
667 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
668 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
669 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
670 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
671 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
672 6D0X 1 A 2140 Antibody, heavy chain 9606
673 6D0X 2 B 1210 Antibody, light chain 9606
674 6BE4 1 H Fab (F598) Heavy Chain 9606
675 6BE4 2 L Fab(F598) Light Chain 9606
676 5TPP 1 L DH270.5 Fab heavy chain 9606
677 5TPP 2 H DH270.5 Fab light chain 9606
678 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
679 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
680 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
681 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
682 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
683 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
684 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
685 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
686 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
687 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
688 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
689 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
690 5TL5 1 L M2177 LIGHT CHAIN 10090
691 5TL5 2 H M2177 HEAVY CHAIN 10090
692 2FX7 1 L Fab 4E10 Light Chain 9606
693 2FX7 2 H Fab 4E10 Heavy Chain 9606
694 6O39 1 A Antibody F2.I Fab, Light chain 9606
695 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
696 5Y9K 1 L belimumab light chain 9606
697 5Y9K 2 H belimumab heavy chain 9606
698 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
699 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
700 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
701 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
702 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
703 6GLW 3 D, L Fab 1D11 - Light chain 9844
704 3WFH 1 A mAb Fab H fragment 10090
705 3WFH 2 B mAb Fab L fragment 10090
706 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
707 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
708 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
709 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
710 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
711 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
712 6GKU 2 H Fab 6F5 - Heavy Chain 9844
713 6GKU 3 L Fab 6F5 - Light chain 9844
714 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
715 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
716 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
717 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
718 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
719 5HI4 3 D, L CAT-2000 FAB light chain 9606
720 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
721 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
722 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
723 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
724 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
725 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
726 3RVW 2 C 4C1 - light chain 10090
727 3RVW 3 D 4C1 - heavy chain 10090
728 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
729 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
730 5XKU 2 B HNIgGA6 light chain 9606
731 5XKU 3 C HNIgGA6 heavy chain 9606
732 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
733 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
734 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
735 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
736 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
737 5HI5 3 D, L CAT-2000 light chain 9606
738 5JO5 1 A, C, E, H 10E8 gHV 9606
739 5JO5 2 B, D, F, L 10E8 gLV 9606
740 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
741 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
742 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
743 5CCK 2 L Antibody 3BC315 Fab light chain 9606
744 6GXX 1 H FAB 1D9 heavy chain 10090
745 6GXX 2 L FAB 1D9 light chain 10090
746 5I76 1 A, C FM318_light_chain 1383439
747 5I76 2 B, D FM318_heavy_cahin 1383439
748 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
749 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
750 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
751 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
752 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
753 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
754 5I18 1 L FAB LIGHT CHAIN 9606
755 5I18 2 H FAB HEAVY CHAIN 9606
756 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
757 4JN1 2 L anti-dabigatran Fab1, light chain 10090
758 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
759 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
760 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
761 4G5Z 2 L canakinumab antibody fragment light chain 9606
762 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
763 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
764 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
765 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
766 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
767 2OK0 2 L Fab ED10 light chain 10090
768 2OK0 3 H Fab ED10 heavy chain 10090
769 3SOB 1 L antibody light chain 9606
770 3SOB 3 H antibody heavy chain 9606
771 6B5M 1 H CIS43 Fab Heavy chain 9606
772 6B5M 2 L CIS43 Fab Light chain 9606
773 5AWN 1 H Heavy chain of 3BC176 Fab 9606
774 5AWN 2 L Light chain of 3BC176 Fab 9606
775 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
776 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
777 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
778 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
779 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
780 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
781 5DR5 2 L AbD09097 Fab light chain 9606
782 6MG5 1 A, B Light chain JTO 9606
783 2IH3 1 A FAB Heavy Chain 10090
784 2IH3 2 B FAB Light Chain 10090
785 4KQ3 1 L CNTO3186 light chain Fab 9606
786 4KQ3 2 H CNTO3186 heavy chain Fab 9606
787 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
788 6AQ7 3 L POM6 FAB light CHAIN 10090
789 4JFX 1 A, L Fab light chain 9606
790 4JFX 2 B, H Fab heavy chain 9606
791 3SGE 1 I, L Light Chain 10090
792 3SGE 2 H, J Heavy Chain 10090
793 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
794 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
795 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
796 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
797 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
798 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
799 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
800 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
801 5FHB 1 H Antibody 100 Fab heavy chain 9606
802 5FHB 2 L Antibody 100 Fab light chain 9606
803 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
804 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
805 1JGU 1 L Antibody Light Chain 10090
806 1JGU 2 H Antibody Heavy Chain 10090
807 4I77 1 H Lebrikizumab heavy chain Fab 9606
808 4I77 2 L Lebrikizumab light chain Fab 9606
809 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
810 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
811 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
812 4O4Y 2 H 2095-2 heavy chain 9986
813 5OBF 1 H fAb Heavy chain 10090
814 5OBF 2 L fAb Light chain 10090
815 6QNK 1 A, C FAB light chain 10090
816 6QNK 2 B, D FAB heavy chain 10090
817 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
818 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
819 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
820 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
821 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
822 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
823 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
824 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
825 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
826 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
827 5MHE 1 L Fab-fragment 10090
828 5MHE 2 H Fab-fragment 10090
829 5YFI 1 L Light chain of Fab fragment 10090
830 5YFI 2 H Heavy chain of Fab fragment 10090
831 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
832 4GLR 3 I, K anti-ptau light chain light chain 9031
833 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
834 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
835 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
836 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
837 4HJG 1 A Trastuzumab light chain 9606
838 4HJG 2 B Trastuzumab heavy chain 9606
839 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
840 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
841 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
842 5I30 1 L Fab PL-2 light chain 10090
843 5I30 2 H Fab PL-2 heavy chain 10090
844 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
845 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
846 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
847 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
848 6CT7 1 B, L BIIB054 Fab light chain 9606
849 6CT7 2 A, H BIIB054 Fab heavy chain 9606
850 3FN0 1 L Fab Z13e1 light chain 9606
851 3FN0 2 H Fab Z13e1 heavy chain 9606
852 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
853 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
854 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
855 4YHI 2 B, L aDabi-Fab2a light chain 9606
856 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
857 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
858 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
859 5YUP 2 L the light chain of the Fab fragment of FVIIa antibody mAb4F5 10090
860 4OSU 1 H SM5-1 Fab Heavy Chain 9606
861 4OSU 2 L SM5-1 Fab Light Chain 9606
862 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
863 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
864 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
865 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
866 1T2Q 1 L Fab NNA7 Heavy Chain 10090
867 1T2Q 2 H Fab NNA7 Light Chain 10090
868 6ELJ 1 A, H fAB heavy chain 9606
869 6ELJ 2 B, L fAB light chain 9606
870 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
871 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
872 4MAU 1 L C2244 light chain SEE REMARK 999 10090
873 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
874 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
875 3LEX 2 B, L 11f10 Antibody Light Chain 10090
876 6B0W 1 L 1710 antibody, light chain 9606
877 6B0W 2 H 1710 antibody, heavy chain 9606
878 6DC7 1 L, M Fab light chain 10090
879 6DC7 2 H, I Fab heavy chain 10090
880 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
881 5VH4 2 B, L Infliximab Fab Light Chain 10090
882 6NOU 1 A scFv derived from ixekizumab 9606
883 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
884 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
885 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
886 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
887 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
888 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
889 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
890 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
891 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
892 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
893 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
894 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
895 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
896 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
897 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
898 3S96 1 A, C 3B5H10 FAB heavy chain 10090
899 3S96 2 B, D 3B5H10 FAB light chain 10090
900 6CBV 1 H Heavy chain, Fab fragment 9606
901 6CBV 2 L Light Chain, Fab fragment 9606
902 4LKX 1 A Fab fragment heavy chain 9606
903 4LKX 2 B Fab fragment light chain 9606
904 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
905 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
906 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
907 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
908 5JW5 1 A, H MEDI8852 Heavy chain 9606
909 5JW5 2 B, L MEDI8852 Light chain 9606
910 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
911 5VH3 2 B, L Infliximab Fab Light Chain 10090
912 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
913 6DCV 2 B, H heavy chain of CBTAU-27.1 Fab 9606
914 5HDQ 2 H Fab Heavy Chain 10090
915 5HDQ 3 L Fab Light Chain 10090
916 4FQ2 1 H Fab heavy chain 9606
917 4FQ2 2 L Fab light chain 9606
918 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
919 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
920 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090
921 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
922 2A77 1 L Immunoglobulin Light Chain 10090
923 2A77 2 H Immunoglobulin Heavy Chain 10090
924 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606
925 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606
926 3GO1 1 L Fab 268-D, light chain 9606
927 3GO1 2 H Fab 268-D, heavy chain 9606
928 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090
929 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090
930 3QWO 1 B, L motavizumab light chain 10090
931 3QWO 2 A, H motavizumab heavy chain 10090
932 3CVI 1 H 25-D1.16 Heavy chain 10090